Prognostic value and development of psycho-social factors and functional aspects in elderly patients with higher risk MDS and AMl. A multi-center observational study.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003601

Enrollment

500

Registered

2012-04-13

Start date

2012-04-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C92.0 D46

Interventions

Group 1: Patients with MDS/AML will be asked to undergo a geriatric and quality of life assessment prior to treatment initiation and every three months thereafter for one year.

Eligibility

Sex/Gender

All

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: Higher risk MDS/AML, age >/= 60 years, written informed consent, anticipated compliance and geographic proximity for follow-up assessments

Exclusion criteria

Exclusion criteria: other malignant diseases not in remission, impaired mental status with inability to fill out questionnaires and to obey simple demands. Trial participation for medical therapy is NOT an exclusion criterion

Design outcomes

Primary

Measure	Time frame
Overall survival within a 2.5 year observation period. Components of a comprehensive geriatric assessment will be evaluated for their prognostic value.	—

Secondary

Measure	Time frame
Independence (Barthel Index), Quality of Life (EORTC QLQ C 30), psychologigal distress (HADS) prior to treatment initiation, and every 3 months for 1 year.	—

Countries

Germany

Contacts

Public ContactMichael Luebbert

Universitätsklinikum Freiburg, Abt. Med. 1 Hämatologie / Onkologie

michael.luebbert@uniklinik-freiburg.de0761 270 32790

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 5, 2026